Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-21,248
Closed -$1.81M 189
2021
Q2
$1.81M Sell
21,248
-12,832
-38% -$1.17M 0.5% 123
2021
Q1
$2.7M Sell
34,080
-1,997
-6% -$130K 0.75% 42
2020
Q4
$2.1M Buy
+36,077
New +$1.7M 0.57% 101
2019
Q2
Sell
-32,224
Closed -$1.35M 127
2019
Q1
$1.35M Hold
32,224
0.6% 89
2018
Q4
$1M Sell
32,224
-15,225
-32% -$566K 0.55% 98
2018
Q3
$2.06M Buy
+47,449
New +$1.34M 0.84% 24

Other funds holding AFMD

EAM Global Investors's AFMD Position: Q3 2021 in Review

EAM Global Investors sold out of Affimed (AFMD) in Q3 2021, closing a stake of 21,248 shares — an estimated $1.81M sold.

EAM Global Investors first reported a position in AFMD in Q3 2018 and held it in 6 quarters. The position peaked at $2.7M in Q1 2021. 126 funds tracked by Wall St. Rank hold AFMD as of Q3 2021.

  • EAM Global Investors reported no remaining Affimed position as of Q3 2021 after selling out during the quarter.
  • EAM Global Investors sold 21,248 Affimed shares in Q3 2021, an estimated $1.81M.
  • EAM Global Investors first reported a position in Affimed in Q3 2018 and held it in 6 quarters.
  • EAM Global Investors's Affimed position peaked at $2.7M in Q1 2021.
  • 126 funds tracked by Wall St. Rank held Affimed as of Q3 2021.

Based on EAM Global Investors's 13F filing for Q3 2021, filed 12 Nov 2021.